Intelligent Route Scouting that Helps Deliver Efficiency and Scalability
The complex nature of small molecule development can present challenges for many pharmaceutical drug developers, specifically smaller operations.
Lonza's AI-Enabled Route Scouting Service reduces project risks by providing you with the insight and commercial intelligence to make decisions now that make the journey from compound to clinical trials more successful and cost-effective.
Explore a suite of resources to understand how to maximize your opportunities with Route Scouting.
Join industry experts as they share how Lonza's custom AI-enabled Route Scouting Service helps partners mitigate API complexity and accelerate IND readiness.
This white paper outlines Lonza's advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.
Dr. Simon Wagschal, Associate Director, Small Molecules R&D at Lonza, describes how increasingly complex molecules require a more advanced approach to Route Scouting.
If you no longer wish to receive communications from Lonza, please opt out here.
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
